Open Access
Open access
volume 9 issue 3 pages 357-365

In vitro proliferative activity of 6-substituted uracil derivatives

Natalia N. Kabal'nova
Nadezhda M. Andriayshina
Vladislav I. Egorov
Lenar R. Valiullin
Alexey A. Nabatov
Ivan S. Raginov
Yurii I. Murinov
Publication typeJournal Article
Publication date2021-05-01
scimago Q2
wos Q4
SJR0.314
CiteScore3.2
Impact factor1.0
ISSN07194250
Drug Discovery
Pharmacology
Pharmaceutical Science
Complementary and alternative medicine
Pharmacy
Abstract

Context: Previously, we investigated the relationship between the nature of the substituent at the 5-position of the uracil ring and the action of the corresponding uracil derivatives on immortalized lung cells. In the present study, we analyzed the impact of some 6-substituted uracil-derivatives on the regeneration potential of the lung cells (LC). Aims: To evaluate uracil derivatives capable of stimulating lung cell proliferation to create drugs that accelerate lung regeneration. Methods: The level of cell proliferation, maximum tolerated dose, and toxic effect of 6-substituted uracil derivatives (9 compounds) were studied on the immortalized lung epithelial cells and compared with the known drug 6-methyluracil. Results: The maximum tolerated dose of compounds for the LC line depends on the chemical structure of the compounds. The highest level of cell proliferation and tolerated was demonstrated when was used 3-methyl-6-cyclopropyluracil and 1-butyl-6-methyluracil. Conclusions: 3-methyl-6-cyclopropyluracil and 1-butyl-6-methyluracil exhibit a high proliferative activity in vitro so they could be recommended for additional studies of regenerative activity in vivo.

Found 

Top-30

Journals

1
2
ChemistrySelect
2 publications, 40%
E3S Web of Conferences
2 publications, 40%
Acta Marisiensis - Seria Medica
1 publication, 20%
1
2

Publishers

1
2
Wiley
2 publications, 40%
EDP Sciences
2 publications, 40%
Walter de Gruyter
1 publication, 20%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
5
Share
Cite this
GOST |
Cite this
GOST Copy
Grabovskii S. A. et al. In vitro proliferative activity of 6-substituted uracil derivatives // Journal of Pharmacy and Pharmacognosy Research. 2021. Vol. 9. No. 3. pp. 357-365.
GOST all authors (up to 50) Copy
Grabovskii S. A., Kabal'nova N. N., Andriayshina N. M., Egorov V. I., Valiullin L. R., Nabatov A. A., Raginov I. S., Murinov Y. I. In vitro proliferative activity of 6-substituted uracil derivatives // Journal of Pharmacy and Pharmacognosy Research. 2021. Vol. 9. No. 3. pp. 357-365.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.56499/jppres20.944_9.3.357
UR - https://doi.org/10.56499/jppres20.944_9.3.357
TI - In vitro proliferative activity of 6-substituted uracil derivatives
T2 - Journal of Pharmacy and Pharmacognosy Research
AU - Grabovskii, Stanislav A.
AU - Kabal'nova, Natalia N.
AU - Andriayshina, Nadezhda M.
AU - Egorov, Vladislav I.
AU - Valiullin, Lenar R.
AU - Nabatov, Alexey A.
AU - Raginov, Ivan S.
AU - Murinov, Yurii I.
PY - 2021
DA - 2021/05/01
PB - Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA)
SP - 357-365
IS - 3
VL - 9
SN - 0719-4250
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Grabovskii,
author = {Stanislav A. Grabovskii and Natalia N. Kabal'nova and Nadezhda M. Andriayshina and Vladislav I. Egorov and Lenar R. Valiullin and Alexey A. Nabatov and Ivan S. Raginov and Yurii I. Murinov},
title = {In vitro proliferative activity of 6-substituted uracil derivatives},
journal = {Journal of Pharmacy and Pharmacognosy Research},
year = {2021},
volume = {9},
publisher = {Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA)},
month = {may},
url = {https://doi.org/10.56499/jppres20.944_9.3.357},
number = {3},
pages = {357--365},
doi = {10.56499/jppres20.944_9.3.357}
}
MLA
Cite this
MLA Copy
Grabovskii, Stanislav A., et al. “In vitro proliferative activity of 6-substituted uracil derivatives.” Journal of Pharmacy and Pharmacognosy Research, vol. 9, no. 3, May. 2021, pp. 357-365. https://doi.org/10.56499/jppres20.944_9.3.357.